AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4
slide-5

Tofajak Tablet

Prescription Icon
Prescription Required

Marketer

Cipla Ltd

Salt Composition

Tofacitinib (5mg)

Overview Tofajak Tablet

Ajovy tablets are indicated for moderate-to-severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. They alleviate joint pain, tenderness, and swelling by suppressing inflammation, and also help retard the progression of bone and joint deterioration. Ajovy may be administered alone or in conjunction with other medications. These tablets can be ingested with or without food, ideally at the same time daily. Dosage is determined by your medical condition and other concurrent medications. Strictly adhere to your physician's prescribed regimen. Discontinue use only under your doctor's guidance, as abrupt cessation may exacerbate your condition. Common side effects include upper respiratory infections, headache, diarrhea, and nasopharyngitis. Less frequent, but potentially serious, adverse reactions such as blood clots and gastrointestinal perforations necessitate immediate medical attention. Consult your doctor regarding any concerns about side effects. Pre-treatment blood work may be required, and initiation of therapy is contraindicated in the presence of any infection. Discuss your medical history, including tuberculosis, herpes zoster, hepatic or renal impairment, hepatitis B or C, and prior history of pulmonary or venous thromboembolism, with your doctor before commencing treatment. Ajovy may increase susceptibility to infections or worsen existing ones; therefore, minimize contact with individuals exhibiting contagious illnesses (e.g., varicella, rubeola, influenza). This medication is not appropriate for individuals under 18 years of age, and its use during pregnancy or breastfeeding should only occur if the potential benefits outweigh the risks as determined by your physician. Regular medical examinations may be necessary during treatment.

Primary Ingredients of Tofajak Tablet

There is no text provided to rephrase.

Uses of Tofajak Tablet

Managing rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis.

Major Benefits of Tofajak Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Tofajak Tablet whole; avoid chewing, crushing, or fracturing it. This medication can be administered with or without food, though consistent timing is recommended.

Common Side effects of Tofajak Tablet:

  • Upper respiratory tract infection
  • Headache
  • Diarrhea
  • Nasopharyngitis (inflammation of the throat and nasal passages)

How to use Tofajak Tablet:

Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing. Tofajak Tablets can be consumed with or without food, although consistent timing is recommended.

How Tofajak Tablet works:

Tofajak tablets function as a Janus kinase inhibitor, suppressing Janus kinase enzyme activity. This mechanism reduces immune system activation and inflammation characteristic of rheumatic conditions and ulcerative colitis.

SAFETY ADVICE

AlcoholAlcoholSAFE

Alcohol consumption alongside Tofajak Tablet presents no known adverse reactions.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Tofajak Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Tofajak Tablets while breastfeeding is likely inadvisable. Scant human evidence indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingSAFE

Driving ability is typically unaffected by Tofajak Tablet.

KidneyKidneyCAUTION

Patients with significantly impaired kidney function should exercise caution when using Tofajak tablets. A modified Tofajak tablet dosage may be necessary. Physician consultation is recommended.

LiverLiverCAUTION

Patients with advanced hepatic impairment should exercise caution when using Tofajak tablets, as dosage modification may be necessary. Physician consultation is recommended.

What if you forget to take Tofajak Tablet :

Should you forget a Tofajak Tablet dose, take it immediately. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Tofajak Tablet

LabelValue
Chemical Category Pyrrolopyrimidine Analog
Developing Habits No.
Treatment Category Pain Relievers
Action Class JAK inhibitors

FAQs on Tofajak Tablet

Tell your doctor about any liver problems before taking Tofajak Tablets. This is because Tofajak Tablets can sometimes raise liver enzymes, so your liver function should be checked beforehand. While Tofajak Tablets can be used in patients with mild to moderate liver impairment, they shouldn't be prescribed to those with severe impairment.
Tofajak Tablet may increase your risk of certain cancers, such as lymphoma and skin cancer, by impacting your immune system. Therefore, tell your doctor if you have or have ever had cancer.
Tofajak tablets treat moderate to severe rheumatoid arthritis, a joint inflammatory disease. It's used when prior treatments prove ineffective or unsuitable, or if initial drug responses are poor. Tofajak may be administered alone or in conjunction with other medications, including methotrexate.
You may begin to feel improvement from Tofajak Tablet within 2 to 8 weeks, with maximum benefits typically observed after 3 to 6 months of use.
Before and during Tofajak Tablet treatment, blood tests may be necessary to monitor for anemia, neutropenia or lymphopenia, high cholesterol, and elevated liver enzymes, and to assess the treatment's impact. Your doctor might also recommend a tuberculosis test beforehand, as Tofajak Tablet could potentially worsen an existing infection.
Tofajak Tablet weakens the immune system, increasing susceptibility to serious infections, including tuberculosis and potentially life-threatening systemic fungal, bacterial, or viral infections. Hospital treatment is recommended for such infections.
Taking Tofajak Tablet and tocilizumab together is not recommended. Since Tofajak Tablet weakens the immune system, combining it with another immunosuppressant like tocilizumab significantly raises your risk of infection and other serious complications.
Tofajak Tablet
190
MRP 220
13% off